EGFR and cancer: AnxA6 displays cancer suppression effects on A431 cells by interacting with protein kinase Cα (PKCα) to reduce EGF-induced tyrosine phosphorylation of EGFR (pY-EGFR) and cycling D1 expression [23–26].